Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study.

Gjærde, Lars I; Shepherd, Leah; Jablonowska, Elzbieta; Lazzarin, Adriano; Rougemont, Mathieu; Darling, Katharine; Battegay, Manuel; Braun, Dominique; Martel-Laferriere, Valerie; Lundgren, Jens D; Rockstroh, Jürgen K; Gill, John; Rauch, Andri; Mocroft, Amanda; Klein, Marina B; Peters, Lars (2016). Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study. Clinical infectious diseases, 63(6), ciw380. Oxford University Press 10.1093/cid/ciw380

Preview	Text Gjaerde_cid ciw380 full.pdf - Accepted Version Available under License Publisher holds Copyright. Download (1MB) | Preview
Preview	Text cid.ciw380.full.pdf - Published Version Available under License Publisher holds Copyright. Download (368kB) | Preview

BACKGROUND

While liver-related deaths in HIV and hepatitis C virus (HCV) co-infected individuals have declined over the last decade, hepatocellular carcinoma (HCC) may have increased. We described the epidemiology of HCC and other liver events in a multi-cohort collaboration of HIV/HCV co-infected individuals.

METHODS

We studied all HCV antibody-positive adults with HIV in the EuroSIDA Study, the Southern Alberta Clinic Cohort, the Canadian Co-infection Cohort, and the Swiss HIV Cohort Study from 2001 to 2014. We calculated the incidence of HCC and other liver events (defined as liver-related deaths or decompensations, excluding HCC) and used Poisson regression to estimate incidence rate ratios.

RESULTS

Our study comprised 7,229 HIV/HCV co-infected individuals (68% male, 90% white). During follow-up, 72 cases of HCC and 375 other liver events occurred, yielding incidence rates of 1.6 (95% confidence interval (CI): 1.3, 2.0) and 8.6 (95% CI: 7.8, 9.5) cases per 1,000 person-years of follow-up, respectively. The rate of HCC increased 11% per calendar year (95% CI: 4%, 19%) and decreased 4% for other liver events (95% CI: 2%, 7%), but only the latter remained statistically significant after adjustment for potential confounders. High age, cirrhosis, and low current CD4 cell count were associated with a higher incidence of both HCC and other liver events.

CONCLUSIONS

In HIV/HCV co-infected individuals, the crude incidence of HCC increased from 2001 to 2014, while other liver events declined. Individuals with cirrhosis or low current CD4 cell count are at highest risk of developing HCC or other liver events.

Interest & Impact

Downloads

207 since deposited on 05 Jul 2016
28 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item